AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
286 hedge funds and large institutions have $3.02B invested in Amedisys in 2023 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 111 increasing their positions, 82 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6.7% more ownership
Funds ownership: 90.63% → 97.34% (+6.7%)
0% more funds holding
Funds holding: 285 → 286 (+1)
79% less call options, than puts
Call options by funds: $18.2M | Put options by funds: $88.3M
Holders
286
Holding in Top 10
13
Calls
$18.2M
Puts
$88.3M
Top Buyers
| 1 | +$124M | |
| 2 | +$43.9M | |
| 3 | +$36.2M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$33.9M |
| 5 |
SCM
Segantii Capital Management
Hong Kong
|
+$32.8M |
Top Sellers
| 1 | -$91.6M | |
| 2 | -$34.6M | |
| 3 | -$30.9M | |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
-$30.5M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$29.4M |